Market Overview:
The global immuno oncology assays market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The market is segmented by type, application, and region. The type segment is further divided into immunoassay, flow cytometry, PCR, and next generation sequencing (NGS). The application segment is divided into research and clinical diagnostics. The North American region dominates the global immuno oncology assays market in terms of revenue share followed by Europe and Asia Pacific.
Product Definition:
Immuno oncology assays are used to measure the immune response of cancer patients to treatment with checkpoint inhibitors. The assays can help clinicians determine whether a patient is responding to therapy and whether the dose of the checkpoint inhibitor needs to be adjusted.
Global Immuno Oncology Assays Market Size Growth Rate : 2016 VS 2021 VS 2027:
Global immuno oncology assay market was valued at USD 683.5 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 11.4% from 2021 to 2027.
Immunoassay:
An immunoassay is a technique that involves the use of antibodies and antigens to detect, measure, and purify substances. The most common types of immunoassays are ELISA (enzyme-linked immunosorbent assay), RIA (radioimmunoassay), flow cytometry, and western blotting.
Application Insights:
The research segment dominated the global immuno oncology assays market in 2016 and is expected to maintain its dominance over the forecast period. This can be attributed to increasing R&D investments by various companies for developing new drugs and vaccines against cancer. For instance, in January 2017, Merck KGaA announced about entering into a collaboration with Iressa Therapeutics Inc., for discovering and developing potential immunotherapies for solid tumors.
The clinical diagnostics segment is anticipated to witness lucrative growth during the forecast period owing to an increase in demand from governments around the world for implementation of mandatory testing policies that are aimed at reducing mortality rates among patients diagnosed with cancerous cells in their bodies.
Regional Analysis:
North America dominated the overall market in terms of revenue share in 2019. The region is expected to maintain its position during the forecast period due to presence of a large number of global immuno oncology assays providers and strong R&D infrastructure. Moreover, increasing prevalence rate of cancer coupled with rising investment by government organizations for development and approval new immuno oncology tests are some other factors contributing toward growth in this region.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rise in investments by global players for expansion into untapped markets such as China & Japan along with growing awareness about advanced diagnostics techniques among people especially healthcare professionals will drive this regional market at a significant CAGR during the estimated time frame. In addition, availability & accessibility ImmunoOncology services at affordable prices will also contribute toward regional demand over next eight years (2022 - 2030).
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for Immuno Oncology Assays market. According to the World Health Organization (WHO), in 2012, there were 14 million new cases of cancer and 8.2 million deaths from cancer worldwide. This number is expected to increase to 21 million new cases and 13 million deaths by 2030. This will create a huge demand for Immuno Oncology Assays products and services, which will drive the growth of this market.
- Rising awareness about immunotherapy: The rising awareness about immunotherapy as a treatment option for various types of cancers is another major growth driver for this market. Immunotherapy involves using the body’s own immune system to fight against tumors, and is becoming an increasingly popular treatment option due its high efficacy rates and low side-effects profile as compared to traditional chemotherapy treatments options .This growing awareness about immunotherapy will lead to increased demand for Immuno Oncology Assays products and services in the coming years, driving the growth of this market..
Scope Of The Report
Report Attributes
Report Details
Report Title
Immuno Oncology Assays Market Research Report
By Type
Global Immuno Oncology Assays Market Size Growth Rate : 2016 VS 2021 VS 2027, Immunoassay, Flow Cytometry, PCR, Next Generation Sequencing
By Application
Global Immuno Oncology Assays Market Share : 2016 VS 2021 VS 2027, Research, Clinical Diagnostics
By Companies
Thermo Fischer Scientific, Roche Diagnostics, Agilent Technologies, Illumina
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
146
Number of Tables & Figures
103
Customization Available
Yes, the report can be customized as per your need.
Global Immuno Oncology Assays Market Report Segments:
The global Immuno Oncology Assays market is segmented on the basis of:
Types
Global Immuno Oncology Assays Market Size Growth Rate : 2016 VS 2021 VS 2027, Immunoassay, Flow Cytometry, PCR, Next Generation Sequencing
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Global Immuno Oncology Assays Market Share : 2016 VS 2021 VS 2027, Research, Clinical Diagnostics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fischer Scientific
- Roche Diagnostics
- Agilent Technologies
- Illumina
Highlights of The Immuno Oncology Assays Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Global Immuno Oncology Assays Market Size Growth Rate : 2016 VS 2021 VS 2027
- Immunoassay
- Flow Cytometry
- PCR
- Next Generation Sequencing
- By Application:
- Global Immuno Oncology Assays Market Share : 2016 VS 2021 VS 2027
- Research
- Clinical Diagnostics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Immuno Oncology Assays Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Immuno-oncology assays are tests that measure the effectiveness of cancer treatments by detecting changes in the immune system.
Some of the key players operating in the immuno oncology assays market are Thermo Fischer Scientific, Roche Diagnostics, Agilent Technologies, Illumina.
The immuno oncology assays market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Immuno Oncology Assays Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Immuno Oncology Assays Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Immuno Oncology Assays Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Immuno Oncology Assays Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Immuno Oncology Assays Market Size & Forecast, 2018-2028
4.5.1 Immuno Oncology Assays Market Size and Y-o-Y Growth
4.5.2 Immuno Oncology Assays Market Absolute $ Opportunity
Chapter 5 Global Immuno Oncology Assays Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Immuno Oncology Assays Market Size Forecast by Type
5.2.1 Global Immuno Oncology Assays Market Size Growth Rate : 2016 VS 2021 VS 2027
5.2.2 Immunoassay
5.2.3 Flow Cytometry
5.2.4 PCR
5.2.5 Next Generation Sequencing
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Immuno Oncology Assays Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Immuno Oncology Assays Market Size Forecast by Applications
6.2.1 Global Immuno Oncology Assays Market Share : 2016 VS 2021 VS 2027
6.2.2 Research
6.2.3 Clinical Diagnostics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Immuno Oncology Assays Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Immuno Oncology Assays Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Immuno Oncology Assays Analysis and Forecast
9.1 Introduction
9.2 North America Immuno Oncology Assays Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Immuno Oncology Assays Market Size Forecast by Type
9.6.1 Global Immuno Oncology Assays Market Size Growth Rate : 2016 VS 2021 VS 2027
9.6.2 Immunoassay
9.6.3 Flow Cytometry
9.6.4 PCR
9.6.5 Next Generation Sequencing
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Immuno Oncology Assays Market Size Forecast by Applications
9.10.1 Global Immuno Oncology Assays Market Share : 2016 VS 2021 VS 2027
9.10.2 Research
9.10.3 Clinical Diagnostics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Immuno Oncology Assays Analysis and Forecast
10.1 Introduction
10.2 Europe Immuno Oncology Assays Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Immuno Oncology Assays Market Size Forecast by Type
10.6.1 Global Immuno Oncology Assays Market Size Growth Rate : 2016 VS 2021 VS 2027
10.6.2 Immunoassay
10.6.3 Flow Cytometry
10.6.4 PCR
10.6.5 Next Generation Sequencing
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Immuno Oncology Assays Market Size Forecast by Applications
10.10.1 Global Immuno Oncology Assays Market Share : 2016 VS 2021 VS 2027
10.10.2 Research
10.10.3 Clinical Diagnostics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Immuno Oncology Assays Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Immuno Oncology Assays Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Immuno Oncology Assays Market Size Forecast by Type
11.6.1 Global Immuno Oncology Assays Market Size Growth Rate : 2016 VS 2021 VS 2027
11.6.2 Immunoassay
11.6.3 Flow Cytometry
11.6.4 PCR
11.6.5 Next Generation Sequencing
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Immuno Oncology Assays Market Size Forecast by Applications
11.10.1 Global Immuno Oncology Assays Market Share : 2016 VS 2021 VS 2027
11.10.2 Research
11.10.3 Clinical Diagnostics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Immuno Oncology Assays Analysis and Forecast
12.1 Introduction
12.2 Latin America Immuno Oncology Assays Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Immuno Oncology Assays Market Size Forecast by Type
12.6.1 Global Immuno Oncology Assays Market Size Growth Rate : 2016 VS 2021 VS 2027
12.6.2 Immunoassay
12.6.3 Flow Cytometry
12.6.4 PCR
12.6.5 Next Generation Sequencing
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Immuno Oncology Assays Market Size Forecast by Applications
12.10.1 Global Immuno Oncology Assays Market Share : 2016 VS 2021 VS 2027
12.10.2 Research
12.10.3 Clinical Diagnostics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Immuno Oncology Assays Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Immuno Oncology Assays Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Immuno Oncology Assays Market Size Forecast by Type
13.6.1 Global Immuno Oncology Assays Market Size Growth Rate : 2016 VS 2021 VS 2027
13.6.2 Immunoassay
13.6.3 Flow Cytometry
13.6.4 PCR
13.6.5 Next Generation Sequencing
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Immuno Oncology Assays Market Size Forecast by Applications
13.10.1 Global Immuno Oncology Assays Market Share : 2016 VS 2021 VS 2027
13.10.2 Research
13.10.3 Clinical Diagnostics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Immuno Oncology Assays Market: Competitive Dashboard
14.2 Global Immuno Oncology Assays Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fischer Scientific
14.3.2 Roche Diagnostics
14.3.3 Agilent Technologies
14.3.4 Illumina
